What is Castle Biosciences's net income?

Castle Biosciences (CSTL) reported net income of -$14.52M in Q1 2026.

How has Castle Biosciences's net income changed year-over-year?

Castle Biosciences's net income increased by 43.8% year-over-year, from -$25.85M to -$14.52M.

What is the long-term trend for Castle Biosciences's net income?

Over 4 years (2021 to 2025), Castle Biosciences's net income has grown at a -6.3% compound annual growth rate (CAGR), from -$31.29M to -$24.16M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Castle Biosciences CSTL Net Income

Net Income at other companies

Labcorp HoldingsLH

$278M+30.5%

VeracyteVCYT

$28.71M+307%

Personalis, Inc.PSNL

-$30.03M-90.7%

NeoGenomicsNEO

-$17.11M+34.0%

Fulgent Genetics, Inc.FLGT

-$25.27M-112%

Cogent Biosciences, Inc.COGT

-$97.35M-35.2%

Segments

By segment

See full

Reportable Segment-$14.52M+43.8%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's net income?: Castle Biosciences (CSTL) reported net income of -$14.52M in Q1 2026.
How has Castle Biosciences's net income changed year-over-year?: Castle Biosciences's net income increased by 43.8% year-over-year, from -$25.85M to -$14.52M.
What is the long-term trend for Castle Biosciences's net income?: Over 4 years (2021 to 2025), Castle Biosciences's net income has grown at a -6.3% compound annual growth rate (CAGR), from -$31.29M to -$24.16M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.